Xponance Inc. Has $599,000 Holdings in Avantor, Inc. (NYSE:AVTR)

Xponance Inc. increased its stake in shares of Avantor, Inc. (NYSE:AVTR) by 3.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 26,254 shares of the company’s stock after purchasing an additional 858 shares during the period. Xponance Inc.’s holdings in Avantor were worth $599,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Fifth Third Bancorp grew its stake in Avantor by 125.3% in the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock valued at $28,000 after acquiring an additional 694 shares during the period. Livforsakringsbolaget Skandia Omsesidigt grew its stake in Avantor by 565.5% in the fourth quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock valued at $30,000 after acquiring an additional 1,131 shares during the period. CKW Financial Group acquired a new position in Avantor in the fourth quarter valued at about $55,000. ORG Partners LLC acquired a new position in Avantor in the fourth quarter valued at about $89,000. Finally, Signaturefd LLC grew its stake in Avantor by 41.7% in the third quarter. Signaturefd LLC now owns 5,979 shares of the company’s stock valued at $126,000 after acquiring an additional 1,759 shares during the period. 95.08% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP James Bramwell sold 6,203 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total value of $151,911.47. Following the transaction, the executive vice president now owns 101,143 shares of the company’s stock, valued at $2,476,992.07. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.50% of the stock is owned by company insiders.

Avantor Price Performance

Shares of NYSE AVTR opened at $23.94 on Friday. The business’s 50 day moving average price is $25.08 and its two-hundred day moving average price is $22.61. The company has a market cap of $16.24 billion, a PE ratio of 49.88, a price-to-earnings-growth ratio of 2.59 and a beta of 1.37. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 1.00. Avantor, Inc. has a twelve month low of $16.63 and a twelve month high of $26.16.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Wednesday, February 14th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.22 by $0.03. Avantor had a return on equity of 14.11% and a net margin of 4.61%. The firm had revenue of $1.72 billion for the quarter, compared to the consensus estimate of $1.70 billion. During the same quarter in the previous year, the business earned $0.32 earnings per share. The business’s revenue was down 4.0% compared to the same quarter last year. On average, analysts predict that Avantor, Inc. will post 1.01 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on AVTR. Barclays boosted their target price on Avantor from $27.00 to $30.00 and gave the company an “overweight” rating in a research note on Wednesday, April 10th. Citigroup boosted their price target on Avantor from $24.00 to $30.00 and gave the company a “buy” rating in a report on Thursday, February 15th. Deutsche Bank Aktiengesellschaft boosted their price target on Avantor from $23.00 to $25.00 and gave the company a “hold” rating in a report on Thursday, April 18th. Royal Bank of Canada boosted their price target on Avantor from $28.00 to $29.00 and gave the company an “outperform” rating in a report on Thursday, February 15th. Finally, Raymond James boosted their price target on Avantor from $22.50 to $26.00 and gave the company an “outperform” rating in a report on Friday, January 26th. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, Avantor currently has a consensus rating of “Moderate Buy” and an average target price of $26.71.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.